Effects of Myxococcus fulvus KYC4048 Metabolites on Breast Cancer Cell Death
0
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Using MCF7 breast cancer cells, we tested the anticancer activity of metabolites from 130 strains of myxobacteria newly isolated in South Korea. Of these, three strains whose metabolites had high anticancer activity and low cell toxicity were selected and identified by their fruiting body morphology, cell morphology, and 16S rRNA sequence. Strains KYC4030 and KYC4048 were determined to be Myxococcus fulvus, whereas strain KYC4081 was identified as Corallococcus coralloides. We found that metabolites of M. fulvus KYC4048 demonstrated no toxicity in normal cells but specifically induced cancer cell death by suppressing the expression of WNT2B. This discovery highlights the value of assessing the metabolic and biomedical potential of myxobacteria, even those that are already known but were isolated from new areas, and the possible use of metabolites from M. fulvus KYC4048 in cancer treatment.
Abstract
Using MCF7 breast cancer cells, we tested the anticancer activity of metabolites from 130 strains of myxobacteria newly isolated in South Korea. Of these, three strains whose metabolites had high anticancer activity and low cell toxicity were selected and identified by their fruiting body morphology, cell morphology, and 16S rRNA sequence. Strains KYC4030 and KYC4048 were determined to be Myxococcus fulvus, whereas strain KYC4081 was identified as Corallococcus coralloides. We found that metabolites of M. fulvus KYC4048 demonstrated no toxicity in normal cells but specifically induced cancer cell death by suppressing the expression of WNT2B. This discovery highlights the value of assessing the metabolic and biomedical potential of myxobacteria, even those that are already known but were isolated from new areas, and the possible use of metabolites from M. fulvus KYC4048 in cancer treatment.
참고문헌 (22)
- Dawid W, "Biology and global distribution of myxobacteria in soils", FEMS Microbiol. Rev., 24, pp.403~427 (2000)[DOI]
- Reichenbach H, "Order VIII. Myxococcales;Bergey's Manual of Systematic Bacteriology, 2nd Ed. Bergey's Manual Trust", pp.1059~1144 (2005)
- Gerth K, "Myxobacteria: proficient producers of novel natural products with various biological activities - past and future biotechnological aspects with the focus on the genus Sorangium", J. Biotechnol., 106, pp.233~253 (2003)[DOI]
- 김용석, "Myxobacteria의 생리활성 물질", 한국미생물·생명공학회지, 31(1), pp.1~12 (2003), 한국미생물·생명공학회
- Weissman KJ, "A brief tour of myxobacterial secondary metabolism", Bioorg. Med. Chem., 17, pp.2121~2136 (2009)[DOI]
- Gerth K, "Epothilons A and B: antifungal and cytotoxic compounds from Sorangium cellulosum (Myxobacteria). Production, physico-chemical and biological properties", J. Antibiot. (Tokyo), 49, pp.560~563 (1996)[DOI]
- Bollag DM, "Epothilones, a new class of microtubule- stabilizing agents with a taxol-like mechanism of action", Cancer Res., 55, pp.2325~2333 (1995)
- 현혜숙, "Isolation of Sorangium cellulosum Carrying Epothilone Gene Clusters", Journal of Microbiology and Biotechnology, 18(8), pp.1416~1422 (2008), 한국미생물·생명공학회
- Stein A, "Ixabepilone: providing new hope for women with breast cancer after anthracycline and taxane failure", Clin. J. Oncol. Nurs., 14, pp.65~71 (2010)[DOI]
- Lee FY, "BMS-247550: a novel epothilone analog with a mode of action similar to paclitaxel but possessing superior antitumor efficacy", Clin. Cancer Res., 7, pp.1429~1437 (2001)
- Fumoleau P, "Novel tubulin-targeting agents: anticancer activity and pharmacologic profile of epothilones and related analogues", Ann. Oncol., 18, pp.v9~v15 (2007)[DOI]
- Schneiker S, "Complete genome sequence of the myxobacterium Sorangium cellulosum", Nat. Biotechnol., 25, pp.1281~1289 (2007)[DOI]
- Wenzel SC, "The impact of genomics on the exploition of the myxobacterial secondary metabolome", Nat. Prod. Rep., 26, pp.1385~1407 (2009)[DOI]
- Ronning CM, "The genomes of Myxococcus xanthus and Stigmatella aurantiaca;Myxobacteria: Multicellularity and Differentiation", pp.285~298 (2008), ASM Press
- Reichenbach H, "The Myxobacteria;The Prokaryotes, 2nd Ed", pp.3416~3487 (1992), Springer Verlag
- 신혜진, "Corallococcus와 Myxococcus 속 점액세균 균주들에 의한 항균 물질의 생산", 한국미생물·생명공학회지, 41(1), pp.44~51 (2013), 한국미생물·생명공학회[DOI]
- 이차율, "Chondromyces crocatus의 순수 분리", 한국미생물·생명공학회지, 37(4), pp.316~321 (2009), 한국미생물·생명공학회
- Rainey FA, "The genus Nocardiopsis represents a phylogenetically coherent taxon and a distinct actinomycete lineage: proposal of Nocardiopsaceae fam. nov", Int. J. Syst. Bacteriol., 46, pp.1088~1092 (1996)[DOI]
- Sproer C, "The correlation between morphological and phylogenetic classification of myxobacteria", Int. J. Syst. Bacteriol., 3, pp.1255~1262 (1999)
- Thompson JD, "CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice", Nucleic Acids Res., 22, pp.4673~4680 (1994)[DOI]
- Clevers H, "Wnt", <TEX>${\beta}$<, Cell, pp.2012, 149[DOI]
- Gerth K, "Sorangium cellulo;Myxobacteria: Multicellularity and Differentiation", pp.329~348 (2008), ASM Press